Takeda Pharmaceutical

Takeda Pharmaceutical, established in 1781, is headquartered in Tokyo, Japan, and operates as a leader in the healthcare industry with a focus on several key business segments, including prescription drugs, consumer healthcare products, oncology, gastroenterology, neuroscience, and rare diseases. Its most recognized brands are Entyvio, Nexium, Leuprorelin, Velcade, and Trintellix, which cater to various therapeutic needs. Takeda's products and services are sold in important markets around the world, notably in the United States, Japan, China, Europe, and extending to additional regions such as Asia, Latin America, and the Middle East. (Powered by AI)